Fortress Biotech
FBIO
66 hedge funds and large institutions have $31M invested in Fortress Biotech in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 5 closing their positions.
15,000% more call options, than puts
Call options by funds: $151K | Put options by funds: $1K
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
27% more capital invested
Capital invested by funds: $24.4M → $31M (+$6.63M)
6% more funds holding
Funds holding: 62 → 66 (+4)
6% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 18
0.08% more ownership
Funds ownership: 0.79% → 0.88% (+0.08%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.33M |
| 2 |
CL
CPWM LLC
Seattle,
Washington
|
+$722K |
| 3 |
Morgan Stanley
New York
|
+$385K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$212K |
| 5 |
Renaissance Technologies
New York
|
+$191K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$169K |
| 2 |
SO
STRS Ohio
Columbus,
Ohio
|
-$137K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$96.3K |
| 4 |
SIM
Spark Investment Management
New York
|
-$86.5K |
| 5 |
HAG
HighPoint Advisor Group
Downers Grove,
Illinois
|
-$48.4K |
FBIO Hedge Fund Activity: Q1 2018 in Review
66 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q1 2018, worth a combined $31M — up 27% from $24.4M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new FBIO positions and 5 closed out — a net gain of 4 holders — while 19 added to existing stakes and 18 trimmed.
The largest buyer was Opaleye Management, opening a new position worth an estimated $1.33M. The largest seller was Jacobs Levy Equity Management, cutting an estimated $169K.
- 66 institutional investors held Fortress Biotech (FBIO) as of Q1 2018, up from 62 in Q4 2017.
- Funds reported $31M of Fortress Biotech stock for Q1 2018, up 27% quarter-over-quarter.
- 9 funds opened new Fortress Biotech positions in Q1 2018 and 5 closed out, a net change of +4 holders.
- The largest Fortress Biotech buyer in Q1 2018 was Opaleye Management, an estimated $1.33M added.
- The largest Fortress Biotech seller in Q1 2018 was Jacobs Levy Equity Management, an estimated $169K sold.
Based on aggregated 13F filings for Q1 2018.